tiprankstipranks
Trending News
More News >

Xavier Harland Insider Profile

4 Followers
Xavier Harland, Chief Financial Officer at Grace Therapeutics, holds 239.63K shares in Grace Therapeutics (Ticker: GRCE), holds 6.71M shares in Geekco Technologies Corporation Class A (Ticker: TSE:GKO). Most recently, Xavier Harland ― shares of Grace Therapeutics on ― for an estimated value of ―.
tipranks
Xavier  Harland

Xavier Harland
Grace Therapeutics (GRCE)
Chief Financial Officer

Ranked #76,961 out of 100,956 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-24.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$772K
72.15%
27.85%
A breakdown of Xavier Harland's holdings

Insider Roles

Grace Therapeutics
(GRCE)
Chief Financial Officer
Geekco Technologies Corporation Class A
(GKO)
Chief Financial Officer, Ten Percent Owner
Roles that Xavier Harland holds in companies

Most Profitable Insider Trade

Stock:
Geekco Technologies Corporation Class A
(GKO)
Rating:Informative Buy
Date:Mar 06, 2024 - Mar 06, 2025
Return:-15.30%
The most profitable trade made by Xavier Harland

Xavier Harland's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Grace Therapeutics
Chief Financial Officer
$608.66K
Geekco Technologies Corporation Class A
Mar 06, 2024
Chief Financial Officer, Ten Percent Owner
Informative Buy
2.50K
C$234.93K
List of latest transactions for each holding click on a transaction to see Xavier Harland's performance on stock

Xavier Harland insider profile FAQ

What is the percentage of profitable transactions made by Xavier Harland?
The percentage of profitable transactions made by Xavier Harland is 0%.
    What is the average return per transaction made by Xavier Harland?
    The average return per transaction made by Xavier Harland is -24.30%.
      What stocks does Xavier Harland hold?
      Xavier Harland holds: GRCE, TSE:GKO stocks.
        What was Xavier Harland’s latest transaction?
        Xavier Harland latest transaction was an Uninformative Buy of ―.
          What was Xavier Harland's most profitable transaction?
          Xavier Harland’s most profitable transaction was an Informative Buy of TSE:GKO stock on March 6, 2024. The return on the trade was -15.30%.
            What is Xavier Harland's role in Grace Therapeutics?
            Xavier Harland's role in Grace Therapeutics is Chief Financial Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.